Amphastar's generic is a synthetic peptide product that the FDA has deemed to be bioequivalent and thus therapeutically equivalent to Eli Lilly’s Glucagon Emergency Kit for Low Blood Sugar.
Dr. Reddy’s, alongside Global Response Aid and Appili Therapeutics, has filed an application on behalf of Reeqonus (favipiravir) tablets to treat mild to moderate COVID-19 in adult patients in Canada.